Indefinite Delivery Contract HHSN271201700006I
Award Date 3/30/17
Last Date to Order 3/31/24
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The U.S. National Center for Advancing Translational Sciences (NCATS) has awarded an indefinite delivery contract (IDC) with a ceiling value of $49,885,703.00 to Purdue University to provide Chemistry, Manufacturing, and Control (CMC) services for the development of drug products. This multiple-award contract has an ultimate completion date of July 31, 2031. The scope of the contract includes a broad range of preclinical services required for the design, development, manufacture, and release...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...
- The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...
- This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mriglobal, a 501(c)(3) not-for-profit research organization, with a potential value of $49,713,679. The contract is for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances for the Division of Preclinical Innovation's translational research programs. The contract...
- This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date. The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS'...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization (CRO). The contract has a total potential value of $3,912,150 and provides comprehensive, integrated drug development, laboratory, and lifecycle management services to support NCATS' bioanalytical method development programs. This...
- This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation. The contract, valued at up to $17,891,012, is to provide CRO (contract research organization) support services for NCATS's Medicinal Chemistry for Lead Optimization program. Under this multiple-award IDC, Alchem Laboratories will perform a variety of preclinical and...
- This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to Research Triangle Institute (RTI International), a non-profit research organization. The contract, with a ceiling value of $17,891,012, aims to provide CRO (Contract Research Organization) support for NCATS' medicinal chemistry programs focused on lead optimization. The first task order, valued at $1,000, is...
- This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to the prime contractor Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The IDC, with a ceiling value of $17,891,012, is to provide CRO (Contract Research Organization) support for NCATS' Medicinal Chemistry for Lead Optimization program. This includes services...
- HHSN271201700006IIndefinite Delivery Contract
- 3Federal Contract Awards
PARENT CONTRACT: CRO SUPPORT FOR NCATS DRUG SUBSTANCE DEVELOPMENT AND MANUFACTURE
Posted 3/30/17
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Other Administrative Action | $0 | 6/21/22 | |
| P00005 | Other Administrative Action | $0 | 3/24/22 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 10/21/21 | |
| P00003 | Other Administrative Action | $0 | 6/19/19 | |
| 2 | Other Administrative Action | $0 | 2/8/18 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN271201700006I-HHSN27100001 | Mriglobal | $131.4k | 8/7/17 | 5/31/22 | 6/9/22 | |
Delivery Order HHSN271201700006I-75N95022F00002 | Mriglobal | $615.5k | 9/29/22 | 6/30/27 | 1/9/24 | |
Delivery Order HHSN271201700006I-75N95022F00001 | Mriglobal | $92.6k | 6/3/22 | 6/2/26 | 4/11/24 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CRO Support for NCATS Drug Substance Development and Manufacture | N01TR-17-2001 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/1/16, 11:41 AM |